1. Home
  2. ISOU vs CTKB Comparison

ISOU vs CTKB Comparison

Compare ISOU & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ISOU

IsoEnergy Ltd.

HOLD

Current Price

$10.72

Market Cap

638.3M

Sector

N/A

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.53

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISOU
CTKB
Founded
2016
1990
Country
Canada
United States
Employees
24
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
638.3M
652.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ISOU
CTKB
Price
$10.72
$4.53
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
113.4K
595.6K
Earning Date
05-26-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$5.94
$2.37
52 Week High
$13.58
$6.18

Technical Indicators

Market Signals
Indicator
ISOU
CTKB
Relative Strength Index (RSI) 51.62 51.86
Support Level $9.62 $4.14
Resistance Level $11.90 $4.60
Average True Range (ATR) 0.70 0.20
MACD 0.07 0.02
Stochastic Oscillator 72.29 50.76

Price Performance

Historical Comparison
ISOU
CTKB

About ISOU IsoEnergy Ltd.

IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Geiger, Thorburn Lake, Full Moon, Edge, Collins Bay Extension, North Thorburn, 2Z Lake, and Madison. It operates in Canada, the United States, and Australia.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: